📊 Evidence-Based Reference

hemodialysis transducer protector

Membrana

Summary: The hemodialysis transducer protector by Membrana is used to prevent contamination in dialysis machines. Key evidence highlights potential breaches leading to infection risks.

FDA Clearance Information

Pathway 510K
Decision Date September 24, 1981
Product Code FIB
Device Class Class 2
Evidence 0 studies

The hemodialysis transducer protector was cleared by the FDA via the 510k pathway on September 24, 1981. It is manufactured by Membrana and classified as a Class 2 device.

What It Is

The hemodialysis transducer protector is a device designed to prevent blood contamination in dialysis machines by acting as a barrier. It is used in clinical settings to ensure the safety and efficacy of hemodialysis procedures.

Clinical Applications

This device is commonly used in hemodialysis centers to protect patients from potential infections during dialysis. It is particularly important in settings with high patient turnover and shared equipment.

Evidence Summary

The available literature includes three studies, ranging from 2003 to 2011, focusing on infection risks associated with hemodialysis. Study types include retrospective and prospective analyses.

Reported Outcomes

Published studies report concerns about infection transmission, particularly hepatitis C, due to potential breaches in the transducer protector. These studies highlight the importance of maintaining device integrity to prevent disease spread.

Safety Profile

Reported complications include potential breaches leading to hepatitis C virus transmission in dialysis settings. These incidents underscore the need for rigorous device maintenance and monitoring.

Evidence Limitations

The evidence is limited by a small number of studies and a focus on infection risks without comprehensive data on other potential complications. Further research is needed to explore long-term outcomes and device efficacy.

Frequently Asked Questions

What are the clinical indications for hemodialysis transducer protector?

The device is indicated for use in hemodialysis to prevent contamination and infection transmission.

What outcomes have been reported in clinical studies?

Studies have reported infection risks, particularly hepatitis C, due to potential breaches in the device.

What complications have been reported?

Safety data indicate potential breaches leading to hepatitis C transmission in dialysis settings.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.